GE Healthcare
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround.
RevoluGen, GE Healthcare Life Sciences Ink DNA Extraction Product Manufacturing Deal
The product uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells.
The partners are preparing to release two updates to Navify Tumor Board that support automatic importation of structured Foundation Medicine test reports.
NeoGenomics Completes Clarient Acquisition
The cancer genetics testing provider acquired its new business unit from GE Healthcare.
Oct 21, 2015
NeoGenomics to Acquire Clarient From GE
Nov 4, 2014
Sep 25, 2014
Sep 4, 2014
Aug 21, 2014
Aug 15, 2014
Feb 11, 2014
Jan 30, 2014
Jan 6, 2014